The term sheet finally arrives.

Global commercialization rights. Attractive economics. Reduced execution risk. It is exactly the deal everyone has been working toward.

So why is the leadership team still debating: “Should we build, or should we partner?”

This tension feels familiar. When a team stalls at this exact crossroads, the impasse is rarely about the numbers. Yet, sometimes internal opinions are too close to the transaction, or too invested in getting the deal across the finish line, to offer an unbiased lens.

In my advisory work on these structural pivots, I find the breakthrough requires stepping away from the valuation model to confront three questions:

1. Who retains the ability to change course? Every forecast assumes a future that doesn’t exist yet. When reality diverges from the model, which side still holds meaningful strategic options? Sometimes the most valuable asset being negotiated isn’t the economics—it’s adaptability.

2. Who gets smarter because the partnership exists? Commercialization doesn’t just generate revenue; it also generates market intelligence. Two years down the road, one side may possess a disproportionate information advantage that fundamentally changes the power dynamic. The question isn’t just who commercializes. It’s who learns.

3. What becomes scarce after the deal closes? In some situations, retaining rights creates strategic freedom. In others, it creates operational complexity that pulls resources away from the next big opportunity.

Most negotiations fixate heavily on the economics. The harder, more critical question is what your company actually becomes after the deal is signed.

In these kinds of high-stakes moments, the most consequential decision isn’t whether to build or partner. It’s ensuring you have a truly objective perspective to map out the trade-offs—before you quietly commit the next 1–2 years to a future you didn’t actually intend to build.